Sign in to fuzzto save your conversations, follow your research and come back anytime.
Corona Remedies
SectorHealthcare
| Metric (₹ crore) | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 291.17 | 313.87 | 297.69 | 293.69 | 346.54 | 361.13 | 342.42 | 353.09 | 422.43 |
| Expenses | 241.65 | 247.06 | 228.27 | 239.47 | 276.96 | 282.66 | 259.26 | 291.07 | 329.3 |
| EBITDA | 49.52 | 66.81 | 69.42 | 54.22 | 69.58 | 78.47 | 83.16 | 62.02 | 93.13 |
| Depreciation | 8.38 | 9.05 | 9.69 | 10.04 | 8.92 | 9.2 | 9.45 | 10.29 | 13.24 |
| EBIT | 41.14 | 57.76 | 59.73 | 44.18 | 60.66 | 69.27 | 73.71 | 51.73 | 79.89 |
| Interest | 3.15 | 2.87 | 2.39 | 2.2 | 1.99 | 1.93 | 1.66 | 1.38 | 2.69 |
| Profit Before Tax | 37.99 | 54.89 | 57.34 | 41.98 | 58.67 | 67.34 | 72.05 | 50.35 | 77.2 |
| Net Profit | 29.95 | 42.97 | 44.95 | 31.55 | 46.2 | 52.32 | 41.27 | 45.33 | 60.11 |
| EPS | 4.9 | 7.03 | 7.35 | 5.16 | 7.55 | 8.55 | 6.75 | 7.41 | 9.83 |
| Metric (₹ crore) | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Operating Cash Flow | 102.7 | 156.76 | 190.49 | 229.48 |
| Investing Cash Flow | -50.28 | -266.64 | -83.86 | -256.15 |
| Financing Cash Flow | -44.75 | 98.55 | -106.57 | 25.28 |
| Net Cash Flow | 7.67 | -11.33 | 0.06 | -1.39 |
| Metric (₹ crore) | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Equity / Shareholders' Funds | 408.52 | 480.41 | 606.34 | 746.86 |
| Total Liabilities | 186.5 | 350.17 | 323.52 | 458.28 |
| Total Assets | 595.02 | 830.58 | 929.86 | 1,205.14 |